CLOSING SOON CFDA 93.310 ↗ Competitive Grant Hard ~50h to apply

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional)

🏛 National Institutes of Health (HHS-NIH11)

⏰ Deadline
Jun 1, 2026 🔥 today
📅 Fiscal Year
FY 2026
📍 Scope
National

Can you apply?

This grant is for researchers holding existing NIH grants or cooperative agreements who need urgent funding for critical changes. Eligible applicants include institutions with active NIH funding for research programs. The supplement supports competitive revisions to ongoing research projects. Clinical trials are optional components. Applications must address time-sensitive needs that impact the existing project's success or continuation.

Supplemental funding requires justification of urgency and how the additional funds extend or improve the current research. Research institutions, universities, and affiliated research organizations with current NIH awards may apply. The revision must strengthen the original project without fundamentally changing its scope.

Eligible applicants
Check your eligibility — what type of organization are you?

Key dates

  1. Mar 4, 2026 Applications open
  2. Jun 1, 2026 Application deadline today
  3. Jul 1, 2026 Award announced
  4. Jul 1, 2026 Project start

This grant is for researchers holding existing NIH grants or cooperative agreements who need urgent funding for critical changes. Eligible applicants include institutions with active NIH funding for research programs. The supplement supports competitive revisions to ongoing research projects. Clinical trials are optional components. Applications must address time-sensitive needs that impact the existing project's success or continuation.

Supplemental funding requires justification of urgency and how the additional funds extend or improve the current research. Research institutions, universities, and affiliated research organizations with current NIH awards may apply. The revision must strengthen the original project without fundamentally changing its scope.

Program description

The National Institutes of Health (NIH) intends to issue a Notice of Funding opportunity to allow applications for competitive revisions of ongoing grants to address specific public health crises that were unforeseen when the original application was submitted. Once this Notice of Funding Opportunity (NOFO) is approved and issued, applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the Notice of Award of the most recent parent award. 

Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to the NOFO once it’s published.

Who can apply

Eligible applicants

Details

This grant is for researchers holding existing NIH grants or cooperative agreements who need urgent funding for critical changes. Eligible applicants include institutions with active NIH funding for research programs. The supplement supports competitive revisions to ongoing research projects. Clinical trials are optional components. Applications must address time-sensitive needs that impact the existing project's success or continuation.

Supplemental funding requires justification of urgency and how the additional funds extend or improve the current research. Research institutions, universities, and affiliated research organizations with current NIH awards may apply. The revision must strengthen the original project without fundamentally changing its scope.

How to apply

Application links

Key dates & requirements

  • 📅 Expected award date: Jul 1, 2026
  • 🚀 Project start date: Jul 1, 2026

Required documents

  • SF-424 (Application for Federal Assistance)
  • Project Narrative (revision description and scientific justification)
  • Budget and Budget Justification
  • Biosketch for key personnel (if new staff added)
  • Current/recent progress report from original award

Program contact

  • 👤 Division of Grants Policy (DGP), Office of Policy for Extramural Research Administration (OPERA)
  • 📧 GrantsPolicy@od.nih.gov
  • 📞 Please contact via email.

Funding track record

Recent awards under CFDA 93.310 from the last 3 years — real organizations that won funding through this same program.

19
awards (3 yrs)
$3.2B
total funded
14
unique recipients
$166.4M
average award

Top 10 Largest Recent Awards

  1. $973,507,476
  2. $383,462,829
  3. $190,396,050
  4. $179,743,190
  5. $169,422,678
  6. $167,922,818
  7. $143,679,156
  8. $134,358,531
  9. $115,739,255
  10. $91,722,927

Top States by Funding

  • NC 5 awards $1,419.5M
  • WA 1 awards $383.5M
  • MD 2 awards $303.8M
  • NY 3 awards $192.1M
  • NJ 1 awards $179.7M

Source: USAspending.gov — federal spending transparency. Data covers last 3 years.

Funding history

Annual funding for this program — Federal obligations (CFDA 93.310). How funding has trended year over year.

2024 $1,174,839,078
2025 $1,062,277,534
2026 est. $28,100,048

FAQ

Who is eligible to apply for this supplement?

Only investigators with existing active NIH grants or cooperative agreements can apply. Your institution must be in good standing with NIH.

What types of research does this supplement support?

Clinical trial work and other research needing urgent revisions to active projects. The supplement must directly support the existing award's objectives.

What makes an application competitive?

Clear justification of urgency. Strong scientific rationale for the revision. Demonstration that additional funds significantly advance the original project.

Are there funding limits?

Supplement budgets vary by institute and original award level. Budget narrative must explain all requested costs.

Can I use this for a brand new research direction?

No. The supplement must support revisions to the existing project, not new research topics.

💡 Tips for applicants

  • Start by clearly defining what has changed since your original award. Why do you need the supplement now?
  • Tie every proposed activity directly to your existing NIH grant aims. Show continuity, not new directions.
  • If including a clinical trial component, ensure it aligns with your original project scope and timelines.
  • Contact your NIH program officer before submitting. They can advise on feasibility and budget expectations.
  • Keep your narrative concise and focused on the urgent need. Reviewers evaluate supplements quickly.

⚠️ Common mistakes

Requesting funds for unrelated new research instead of revisions to the existing project. Failing to justify true urgency or time sensitivity. Submitting without pre-award notification to your NIH program officer.

Similar grants

Source: Grants.gov · FY 2026 · Last updated May 27, 2026

Closes today Jun 1, 2026
Apply →